Release Details

image description

CELESTICA COMPLETES ALLIED PANELS ACQUISITION

Aug 30, 10 at 5:47 PM EDT

TORONTO, Aug 30, 2010 /PRNewswire via COMTEX/ --

Celestica Inc. (NYSE, TSX: CLS), a global leader in the delivery of end-to-end product lifecycle solutions, today announced it has completed its acquisition of Allied Panels Entwicklungs-und Produktions Gmbh ("Allied Panels"), a leading medical engineering and manufacturing service provider, offering concept-to-full production solutions, with a core focus on diagnostic imaging products.

The acquisition of Austria-based Allied Panels significantly expands Celestica's capabilities in the healthcare diagnostics and imaging market, and broadens its healthcare global network to include a centre of excellence in Europe.

"This acquisition represents a critical step in executing our healthcare strategy to deliver deep technical capability, engineering skills and regulatory expertise to our customers through strategically located regional healthcare centers of excellence," said Sandra Ketchen, Vice President, Healthcare, Celestica. "I am pleased to be working with Allied Panels to drive Celestica's healthcare strategy."

The company will now be referred to as AlliedPanels, a Celestica healthcare company. The details of the transaction are not being disclosed.

About Celestica

Celestica is dedicated to delivering end-to-end product lifecycle solutions to drive our customers' success. Through our simplified global operations network and information technology platform, we are solid partners who deliver informed, flexible solutions that enable our customers to succeed in the markets they serve. Committed to providing a truly differentiated customer experience, our agile and adaptive employees share a proud history of demonstrated expertise and creativity that provides our customers with the ability to overcome any challenge.

For further information on Celestica, visit its website at www.celestica.com

The company's security filings can also be accessed at www.sedar.com and www.sec.gov.

Safe Harbour and Fair Disclosure Statement

Statements contained in this press release which are not historical facts are forward-looking statements. Such forward-looking statements are predictive in nature, and may be based on current expectations, forecasts or assumptions involving risks and uncertainties that could cause actual outcomes and results to differ materially from the forward-looking statements themselves. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," or similar expressions, or may employ such future or conditional verbs as "may", "will", "should," or "would," or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the U.S. Private Securities Litigation Reform Act of 1995 and in any applicable Canadian securities legislation. Forward looking statements are not guarantees of future performance. Risks and uncertainties, as well as other information related to the Company, are discussed in the Company's various public filings at www.sedar.com and www.sec.gov, including our Annual Report on Form 20-F and subsequent reports on Form 6-K filed with the Securities and Exchange Commission and our Annual Information Form filed with the Canadian Securities Commissions. Forward-looking statements are provided for the purpose of providing information about management's current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes.

SOURCE Celestica Inc.



The information that you are accessing on this website may include forward-looking statements related to our future growth, trends in our industry, our financial and operational results and performance that are based on current expectations, forecast and assumptions involving risk and uncertainties that could cause actual outcomes and results to differ materially.


Read the full Cautionary Note here